GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Intervacc IVACC.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.79

+1.93%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Intervacc — daily IVACC

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Intervacc on TradingView ↗
Market value
SEK 235.8m
Last close × shares
Volume
840.3k
Shares, 9 Nov 2026

About Intervacc

Its shares trade on Nasdaq Stockholm under the ticker IVACC.ST. It has been listed since 7 April 2017. In the fiscal year to 31 December 2025, it reported revenue of SEK 20.1m and a net loss of SEK 80.8m. At that date it held total assets of SEK 294.4m and shareholders' equity of SEK 274.9m.

Intervacc AB engages in the development of novel veterinary vaccines. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2017-04-07. The company develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The firm operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. The company offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.

Figures and description from our data supplier, not checked against the company's own report.

More about Intervacc →

Latest on Intervacc

Our reporting

We have not reported on Intervacc yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.06 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Intervacc's ticker?

Intervacc trades as IVACC.ST on Nasdaq Stockholm, under ISIN SE0009607252.

What was Intervacc's last closing price?

0.79 on 9 Nov 2026. The figure is in SEK and is never converted.

When does Intervacc next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.